EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Iron overload in steatotic hepatocytes drives systemic metabolic dysfunction via alterations in hepatokine production

Hye Jin Jo, Ayoung Kim, Hyunsoo Rho, Ae Kyung Park, Gil-Hwan Kim, Seo Jeong Jo, Hao Yuxin, You-Jung Hong, Ji Min Yeon, Hwang Chan Yu, Mi-Young Song, Jeongwoo Park und 15 weitere

Journal of Clinical Investigation · 15.06.2026 · 136 (12)

DOI: 10.1172/jci196374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 28.04.2026. Verfasst von Hye Jin Jo und 26 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju, Republic of Korea. Hauptthemen laut MEDLINE: Hepatocytes, Iron Overload, Fatty Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Bio & Medical Technology Development Program of the NRF, Basic Science Research Program through the NRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron overload has emerged as a significant risk factor for metabolic dysfunction–associated steatotic liver disease (MASLD), a growing global health concern. Despite this association, the precise mechanisms by which hepatic iron and its regulatory genes connect liver pathology to systemic metabolic dysfunction remain elusive. Here, we demonstrate that humoral signals originating from iron-overloaded hepatocytes acted as critical mediators driving systemic metabolic dysfunction in MASLD. Ferroportin (FPN, SLC40A1), the sole cellular iron exporter, exhibited markedly reduced expression in hepatocytes of both patients with MASLD and mouse models of the disease, concomitant with hepatic iron accumulation. Functionally, hepatocyte-specific FPN deletion significantly exacerbated diet-induced obesity and insulin resistance, with these metabolic perturbations accompanied by decreased energy expenditure and impaired thermogenic capacity. Mechanistically, we establish that hepatic iron accumulation resulting from FPN deficiency enhanced the production of 2 specific hepatokines, fetuin-A and LECT2, through activation of the transcription factor FoxO1. Notably, therapeutic interventions — including genetic silencing of these hepatokines, hepatocyte-specific FPN overexpression, or oral iron chelation — effectively reversed the metabolic dysfunction phenotypes. These findings provide critical insights into the pathophysiological mechanisms linking MASLD to systemic metabolic disorders and highlight promising therapeutic strategies to combat these diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesIron OverloadFatty LiverAnimalsMiceCation Transport ProteinsHumansFerroportinForkhead Box Protein O1Mice, KnockoutIntercellular Signaling Peptides and ProteinsMaleIronLiverInsulin ResistanceObesity

Stichwörter der Autor:innen

DiabetesHepatologyHomeostasisMetabolismObesity

Substanzen

Cation Transport ProteinsFerroportinForkhead Box Protein O1Foxo1 protein, mouseIntercellular Signaling Peptides and ProteinsIron

Autor:innen und Institutionen

  • School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju, Republic of Korea.
  • College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Goyang-si, Gyeonggi-do, Republic of Korea.
  • Department of Pathology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • College of Pharmacy, Graduate School of Pharmaceutical Sciences, and.
  • Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea.

Förderung

  • National Research Foundation of Korea
  • Bio & Medical Technology Development Program of the NRF
  • Basic Science Research Program through the NRF

Zitieren

APA

Jo, H. J., Kim, A., Rho, H., Park, A. K., Kim, G. H., Jo, S. J., Yuxin, H., Hong, Y. J., Yeon, J. M., Yu, H. C., Song, M. Y., Park, J., Jeong, Y. H., Hong, S. E., Yeon, H. J., Oh, D. Y., Scherer, P. E., Choi, C. S., Lee, D. H., …, & Han, C. Y. (2026). Iron overload in steatotic hepatocytes drives systemic metabolic dysfunction via alterations in hepatokine production. Journal of Clinical Investigation, 136(12). https://doi.org/10.1172/jci196374

Vancouver

Jo HJ, Kim A, Rho H, Park AK, Kim GH, Jo SJ, et al. Iron overload in steatotic hepatocytes drives systemic metabolic dysfunction via alterations in hepatokine production. Journal of Clinical Investigation. 2026;136(12). doi:10.1172/jci196374

BibTeX
@article{Jo2026,
  author = {Jo, Hye Jin and Kim, Ayoung and Rho, Hyunsoo and Park, Ae Kyung and Kim, Gil-Hwan and Jo, Seo Jeong and Yuxin, Hao and Hong, You-Jung and Yeon, Ji Min and Yu, Hwang Chan and Song, Mi-Young and Park, Jeongwoo and Jeong, Yeon Hee and Hong, Sung Eun and Yeon, Hyo Jin and Oh, Da Young and Scherer, Philipp E and Choi, Cheol Soo and Lee, Dong Hyeon and Ki, Sung Hwan and Kang, Keon Wook and Choi, Murim and Park, Byung-Hyun and Bae, Eun Ju and Kim, Sang Geon and Kim, Won and Han, Chang Yeob},
  title = {Iron overload in steatotic hepatocytes drives systemic metabolic dysfunction via alterations in hepatokine production},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {12},
  doi = {10.1172/jci196374}
}
Kostenlos starten →